We are live on
!
Find out more
VBCG
Valley Brook Capital Group Portfolio holdings
AUM
$176M
1-Year Est. Return
41.06%
This Fund
S&P 500
This Quarter
Est. Return
+11.6%
1 Year Est. Return
+41.06%
3 Year Est. Return
+106.25%
5 Year Est. Return
+144.47%
10 Year Est. Return
–
AUM
$134M
AUM Growth
+$6.21M
(+4.9%)
Cap. Flow
-$4.16M
Cap. Flow
% of AUM
-3.11%
Top 10 Holdings %
Top 10 Hldgs %
40.05%
Holding
116
New
5
Increased
41
Reduced
43
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$203K |
| 2 |
Boeing
BA
|
+$190K |
| 3 |
Citigroup
C
|
+$184K |
| 4 |
Constellation Energy
CEG
|
+$179K |
| 5 |
Amazon
AMZN
|
+$110K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$3.29M |
| 2 |
Apple
AAPL
|
+$919K |
| 3 |
NVIDIA
NVDA
|
+$350K |
| 4 |
Microsoft
MSFT
|
+$217K |
| 5 |
Broadcom
AVGO
|
+$190K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.45% |
| 2 | Industrials | 16.15% |
| 3 | Financials | 10.54% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
101
Idexx Laboratories
IDXX
$46.5B
| $228K | 0.17% |
+425
| New | +$203K |
|
|
K
102
DELISTED
Kellanova
K
| $227K | 0.17% |
2,850
| – | – |
|
103
Merck
MRK
$317B
| $224K | 0.17% |
2,836
-390
| -12% | -$31K |
|
104
S&P Global
SPGI
$119B
| $224K | 0.17% |
425
| – | – |
|
105
AT&T
T
$162B
| $220K | 0.16% |
7,600
| – | – |
|
|
106
Constellation Energy
CEG
$93.2B
| $218K | 0.16% |
+676
| New | +$179K |
|
|
107
Citigroup
C
$224B
| $217K | 0.16% |
+2,550
| New | +$184K |
|
108
Vanguard Morningstar Mid-Cap ETF
VO
$108B
| $217K | 0.16% |
3,100
-368
| -11% | -$24.2K |
|
109
Quest Diagnostics
DGX
$26.3B
| $216K | 0.16% |
1,200
| – | – |
|
|
110
Boeing
BA
$184B
| $210K | 0.16% |
+1,004
| New | +$190K |
|
111
Invesco Financial Preferred ETF
PGF
$672M
| $178K | 0.13% |
12,600
| – | – |
|
|
MCR
112
DELISTED
MFS Charter Income Trust
MCR
| $152K | 0.11% |
23,850
| – | – |
|
113
AGNC Investment
AGNC
$12.6B
| $114K | 0.09% |
12,425
| – | – |
|
114
Nuveen Preferred & Income Opportunities Fund
JPC
$2.9B
| $108K | 0.08% |
13,489
| – | – |
|
|
GUT
115
Gabelli Utility Trust
GUT
$558M
| $98.6K | 0.07% |
+17,000
| New | +$92K |
|
|
116
UnitedHealth
UNH
$367B
| – | – |
-6,272
| Closed | -$3.29M |
|
Similar funds
RAS
MFFIA
NA
XWL
USPCM
PFP
DAM
LWM
Valley Brook Capital Group's Q2 2025 Portfolio in Review
As of Q2 2025, Valley Brook Capital Group held 116 positions worth $134M, up 4.9% from $127M the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Valley Brook Capital Group withdrew a net $4.16M in Q2 2025, closing 1 position and reducing 43 holdings. Its most notable exit was UnitedHealth, an estimated $3.29M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Industrials and Financials.
Against the trend, Valley Brook Capital Group opened a new position in Idexx Laboratories worth $228K.
- Valley Brook Capital Group's largest Q2 2025 buy was Idexx Laboratories: 425 shares worth $228K.
- Valley Brook Capital Group added most to Amazon in Q2 2025, an estimated $110K increase.
- Valley Brook Capital Group's biggest Q2 2025 reduction was Apple, cutting an estimated $919K.
- Valley Brook Capital Group fully exited UnitedHealth in Q2 2025, selling an estimated $3.29M.
- Valley Brook Capital Group's ten largest holdings make up 40% of its $134M portfolio in Q2 2025.
- Valley Brook Capital Group opened 5 new positions and closed 1 in Q2 2025.
- Valley Brook Capital Group's portfolio value rose 4.9% quarter-over-quarter to $134M.
Based on Valley Brook Capital Group's 13F filing for Q2 2025, filed 25 Jul 2025.